Parnaparin: confronto con le altre eparine a basso peso molecolare
Sodium parnaparin is a low molecular weight heparin (LMWH). The introduction of this drug class has represented a medical advancement in the prevention and therapy of thromboembolic pathologies, as they maintain the same efficacy of unfractionated heparin, but with simplified dosing regimens and red...
Main Author: | Lorenzo Pradelli |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd Medical Publishers
2005-09-01
|
Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
Subjects: | |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/837 |
Similar Items
-
Parnaparin: review of the literature
by: Lorenzo Pradelli
Published: (2008-03-01) -
Parnaparin: confronto con le altre eparine a basso peso molecolare
by: Lorenzo Pradelli, et al.
Published: (2004-03-01) -
Clinical use of parnaparin in major and minor orthopedic sugery: a review
by: Stefano Bugamelli, et al.
Published: (2008-10-01) -
La tromboprofilassi post-chirurgica e la terapia del tromboembolismo venoso con eparine a basso peso molecolare: ruolo della bemiparina in una strategia di minimizzazione dei costi
by: Lorenzo Pradelli, et al.
Published: (2004-12-01) -
Anticoagulation in COVID-19: why, what, and when
by: Khaled M Taema
Published: (2021-01-01)